HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Chemoradiotherapy for lung, esophageal, and uterine cervix cancer].

Abstract
Some early cancer is completely cured by radiation therapy alone. In many advanced cases, however, local control rates are low with radiation therapy. Chemoradiotherapy has recently become a standard treatment to improve therapeutic-results. The objective of chemoradiotherapy is to improve local tumor control, to control potential systemic metastases, or both. In chemoradiotherapy, drugs effective against primary tumors are selected, platinum compounds often being key drugs. Regarding the timing of radiation and chemotherapy, three patterns are possible: sequential, concurrent, and alternating. In the sequential pattern, the severity of acute toxicity decreases; however, an extended total therapeutic period can lower the antitumor effect. In the concurrent pattern, the maximum antitumor effect is expected because of the simultaneous action of radiation and chemotherapy, but the severity of acute toxicity is intensified to the extent that treatment withdrawal or dose reduction may be required. In the alternating pattern, radiation therapy is quit transiently during chemotherapy. As a result, the irradiation period is extended so that the antitumor effect might be reduced. To explore the methods and results of chemoradiotherapy in each disease, this paper also reports on the results of meta-analysis and randomized trials. Although chemoradiotherapy is not recommended for all patients, it is considered to be more appropriate than radiation therapy alone in patients who have good performance status and adequate organ function.
AuthorsMasahiro Tanaka
JournalNihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica (Nihon Igaku Hoshasen Gakkai Zasshi) Vol. 62 Issue 9 Pg. 479-83 (Aug 2002) ISSN: 0048-0428 [Print] Japan
PMID12235864 (Publication Type: English Abstract, Journal Article, Review)
Topics
  • Combined Modality Therapy
  • Esophageal Neoplasms (therapy)
  • Female
  • Humans
  • Lung Neoplasms (therapy)
  • Uterine Cervical Neoplasms (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: